Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)

Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has a major impact on transplant recipients, with mortality rates up to 20%. Therefore, the effect of established messenger RNA (mRNA)-based SARS-CoV-2 vaccines have to be evaluated for solid organ transplant patients (SOT) since they...

Full description

Bibliographic Details
Main Authors: Johannes Korth, Michael Jahn, Oliver Dorsch, Olympia Evdoxia Anastasiou, Burkhard Sorge-Hädicke, Ute Eisenberger, Anja Gäckler, Ulf Dittmer, Oliver Witzke, Benjamin Wilde, Sebastian Dolff, Andreas Kribben
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Viruses
Subjects:
SARS-Cov-2 vaccination
renal transplant recipients
renal transplantation
COVID-19
Online Access:https://www.mdpi.com/1999-4915/13/5/756

Internet

https://www.mdpi.com/1999-4915/13/5/756

Similar Items